Zacks PEG Ratio Strategy Highlights: Concho Resources, Petro-Canada, PDL BioPharma,...

Zacks PEG Ratio Strategy Highlights: Concho Resources, Petro-Canada, PDL BioPharma, Cimarex Energy

CHICAGO--(Business Wire)--
If you like to use a company's P/E ratio to determine its value,
then you'll love using the PEG Ratio Profit Track. The PEG Ratio can
calculate if a stock is undervalued relative to its expected future
growth. Find out which companies offer the greatest value regardless
of growth rate to enjoy stellar returns. Four stocks meeting this
screen's exclusive criteria are: Concho Resources, Inc. (NYSE: CXO),
Petro-Canada (NYSE: PCZ), PDL BioPharma Inc. (NASDAQ: PDLI), Cimarex
Energy Co. (NYSE: XEC). View the entire list of stocks for the PEG
Ratio Profit Track at http://at.zacks.com/?id=1837

Here are details about four companies currently identified by the
PEG Ratio Profit Track:

Concho Resources, Inc. (NYSE: CXO) enjoys a Zacks #1 Rank and a
PEG ratio of .14, making this undervalued stock a great pick for the
PEG Ratio profit track. In the second quarter, CXO reported earnings
of 55 cents per share, compared to 29 cents in the previous quarter.
In addition, the company sports an average broker recommendation of
1.40 and a 12-month trailing PE of 26.18. CXO is an independent oil
and natural gas company engaged in the acquisition, development,
exploitation and exploration of oil and natural gas properties.

Petro-Canada (NYSE: PCZ) is a major Canadian oil and gas company
with a strong reputation for environmental stewardship and corporate
responsibility. The Zacks #1 Rank earned its place on the PEG Ratio
profit track with an average broker recommendation of 1.88 and a PEG
ratio of .42. PCZ reported year-over-year first quarter earnings of
$3.06 per share, compared to $1.56 per share. Analysts were expecting
the company to report $2.46.

PDL BioPharma Inc. (NASDAQ: PDLI) reported year-over-year second
quarter net earnings of 36 cents per share, compared to 26 cents. The
company placed on the PEG Ratio profit track with a 12-month trailing
PE of 28.37 and an average broker recommendation of 2.00. PDLI is a
biopharmaceutical company focused on the research and development of
novel therapies for inflammation and acute cardiac conditions and
cancer.

Cimarex Energy Co. (NYSE: XEC) is an independent oil and gas
exploration and production company that sports an average broker
recommendation of 2.25 and a PEG ratio of .45. In the second quarter,
XEC delivered a 5.51% surprise and reported net earnings of $2.68 per
share, compared to 93 cents last year. On top of that, the company is
currently enjoying a Zacks #1 Rank and a per share price of $128.14.

Discover all the current stocks currently on the PEG Ratio Profit
Track at: http://at.zacks.com/?id=1868

About Profit Tracks

What is a "Profit Track"? Each Profit Track is a successful stock
picking strategy with proven results through the Bear Market of
2001-2002 and the Bull run started in 2003. On Zacks.com we have
created these nine unique screens to offer investors great strategies
to potentially outperform the market in the years ahead. In 2006, the
Low Price Stocks strategy was the top performing Profit Track with a
return of +56.5% followed by the Discounted Fundamental screen with a
+34% return. To see all nine strategies along with philosophy, past
performance and current stocks, go to http://at.zacks.com/?id=1838.

All the Profit Track strategies were created and backtested using
the Research Wizard software from Zacks Investment Research. If you
like this screening strategy, but want to narrow down the list of
stocks and even improve the performance, then you should start a free
trial to this powerful stock picking tool. Learn more about the
Research Wizard free trial offer and our new special report "Top 10
Stock Screening Strategies" at http://at.zacks.com/?id=2156

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which
was formed in 1978 by Leonard Zacks. As a PhD in mathematics Len knew
he could find patterns in stock market data that would lead to
superior investment results. Amongst his many accomplishments was the
formation of his proprietary stock picking system; the Zacks Rank,
which continues to outperform the market by nearly a 3 to 1 margin.
The best way to unlock the profitable stock recommendations and market
insights of Zacks Investment Research is through our free daily email
newsletter; Profit from the Pros. In short, it's your steady flow of
Profitable ideas GUARANTEED to be worth your time! Register for your
free subscription to Profit from the Pros at
http://at.zacks.com/?id=1841

Zacks Investment Research is under common control with affiliated
entities (including a broker-dealer and an investment adviser), which
may engage in transactions involving the foregoing securities for the
clients of such affiliates.

Visit http://www.zacks.com/performance for information about the
performance numbers displayed in this press release.

Disclaimer: Past performance does not guarantee future results.
Investors should always research companies and securities before
making any investments. Nothing herein should be construed as an offer
or solicitation to buy or sell any security.

Zacks.com
Alla Kushner, 312-265-9208
pr@zacks.com
www.Zacks.com

Copyright Business Wire 2008